Replies to post #737470 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

Now this is interesting:

"Main pro-and con-points listed, according to them APPROVAL is NOT a done thing, everthing is wobbly.

MY key-take from the report : NWBO-mgmt. is NOT doing its job towards shareholders and the public, as it is a very important treatment that would deserve a much better communication."

Well at one point attacking the company and mgt and says approval not done deal. But at the same post says called DCVax-L very important treatment. So he saying we need treatment for cancer patients but his beef is against NWBO mgt for not communicating with shareholders. Hmmmm. Another hit piece.

You don't have write this in seeking alpha for this hit piece.. Some say communication is fine during this period some like me says we need a better communication.,

[jtaylor042]

There you'll find a pretty objective report

....

🤣

[XMaster2023]

I would not believe a word you read in Seeking Alpha Ltd. which is privately held. Originally Founded by David Jackson. The current ownership structure likely involves private equity investors and other stakeholders.

Private Equity Investment: Seeking Alpha has received funding from private equity firms, which would give them significant ownership stakes.

Founder and Management: David Jackson, as founder and CEO, likely retains some ownership and significant influence in the company's direction.

However, I would bet that one of the equity investors has a relationship with one of the 7 market makers. Just like the paid thugs on this website, don’t believe all you read,

[XMaster2023]

Roa-CH
Galzus Research is a financial blogger on the Seeking Alpha platform.
Ownership: Galzus Research is likely owned and operated by an individual or a small team.
* Seeking Alpha: Galzus Research operates as a contributor on the Seeking Alpha platform. Seeking Alpha provides the platform for publishing their research and analysis.
Again, who owns Galzus Research? A company, owned by a Company, owned by a market maker?

[JTORENCE]

ROS-CH the long shareholders don't need a damn article to know that LP and the over the hill gang don't give a rat's ass about shareholders. They only need us at ASM 's to approve their yearly bonuses, increased compensation and additional shares for dilution.imo

[dstock07734]

There are a bunch of posters on my ignore list. I feel you have the same IQ as those posters. Ignored.

[Galzus Research]

I appreciate you amplifying my article, ROS-CH. I understand that NWBO has one of the most active retail shareholder bases in all of biotech. So I thought I'd jump in here in case any of you guys have questions about the article but don't have access to Seeking Alpha.

Because I have a limited number of posts, I'd like to go ahead and respond to a few things on this reply chain I'm seeing so far:

1) While I am writing for Seeking Alpha as a side gig, I have no affiliation/employment with Seeking Alpha. I work in the oncology world, though.

2) I, personally, own the Galzus Research pseudonym. There was a time where I wrote with my real name, but I elected to stop doing that after there were issues related to doxxing and contacting my employer. I would rather be able to say what I want without fear of outsized repercussions. It only takes one crazy to cause a lot of trouble.

3) I agree that on the whole Seeking Alpha has a lot of unsophisticated writers, and I would count myself among them, at least on the financial side of things. The fact that we're asked to make "calls" is emblematic of this, as someone pointed out my 30% "win" rate. In biotech, too much happens that is completely unpredictable to bother with trying to predict, which is why I talk about the buy/sell not as recommendations, but where my sentiment falls on the risk/benefit continuum. "Sell" here, as I stated in my article, would be more along the lines of "I would strongly recommend my brother not leverage himself to invest in this one" as opposed to "OMFG please sell all your holdings in this!"

But I thank you all for reading, again, and hope there was something to gain. I understand the subject of criticism is a sore topic with the ongoing lawsuit. I do not feel like NWBO is a sure loss, but there are a lot of concerning factors related to this potential approval that I would definitely be cautious about.